secwatch / observer
8-K filed August 11, 2021, 7:59 PM ET ticker TWAV CIK 0000746210
earnings confidence high sentiment negative materiality 0.65

Oblong Q2 revenue $2.0M (-29%); net loss narrows; raises $11.5M; appoints two directors

TaoWeave, Inc.

2021-Q2 EPS reported -$0.29 vs consensus -$55.08 ▲ beat (+99.5%)

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Deborah Meredith

Director
TWAV · TaoWeave, Inc.
Effective
2021-08-16
Filed
August 11, 2021, 7:59 PM ET
appointed Matthew Blumberg, age 50, and Deborah Meredith, age 62, to fill the two vacant seats created by the expansion of the Board, effective as of August 16, 2021.
Appointed

Matthew Blumberg

Director
TWAV · TaoWeave, Inc.
Effective
2021-08-16
Filed
August 11, 2021, 7:59 PM ET
appointed Matthew Blumberg, age 50, and Deborah Meredith, age 62, to fill the two vacant seats created by the expansion of the Board, effective as of August 16, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Deborah Meredith was appointed as Director at TaoWeave, Inc..

Action
appointed
Role
Director
Exact text from the filing
appointed Matthew Blumberg, age 50, and Deborah Meredith, age 62, to fill the two vacant seats created by the expansion of the Board, effective as of August 16, 2021.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Blumberg was appointed as Director at TaoWeave, Inc..

Action
appointed
Role
Director
Exact text from the filing
appointed Matthew Blumberg, age 50, and Deborah Meredith, age 62, to fill the two vacant seats created by the expansion of the Board, effective as of August 16, 2021.
View on SEC.gov

TaoWeave, Inc. filing history →

Source: SEC EDGAR
accession 0000746210-21-000056
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.